Dr. Elizabeth Mobley was recently named a Center of Excellence by Axonics for Bulkamid. This newer FDA Approved treatment option is a minimally-invasive and long-lasting treatment option for bladder leaks caused by stress urinary incontinence (SUI)
Bladder leakage is common in women, with 1 in 3 suffering from SUI at some point in their lives. Stress urinary incontinence tends to develop as women get older, often during or after pregnancy. The leaks are caused by weakness in the pelvic floor, preventing the urethra from closing fully when sudden pressure is put on the bladder. This can allow urine to leak out during normal daily activities such as coughing, laughing, exercising or lifting an object. Women who experience bladder leaks because of SUI can have severely decreased quality of life.
Bulkamid is a soft, water-based gel delivered via a series of small injections into the urethral wall. Once it is injected, the volume of the gel adds “bulk” to the urethra, supporting the closing mechanism of the urethra and providing better control of urine. Similar to some facial fillers, it remains in the body over time without causing reactions in the surrounding tissue, resulting in durable, long-lasting relief from symptoms .
Benefits of Bulkamid:
- Safe and effective: In a clinical study, 92% of women reported being cured or improved
- Simple procedure: A series of 3 – 4 small injections that takes just 10 – 15 minutes
- Long-lasting symptom relief: Bulkamid is clinically proven to deliver symptom relief out to seven years
- A more appealing treatment option: A majority of women with SUI chose Bulkamid before other surgical treatment options in a 2020 clinical study
Dr. Mobley has a commitment to helping women who suffer from incontinence and she has been designated a Bulkamid Center of Excellence by Axonics, Inc. The designation recognizes her for her expertise with Bulkamid, the quality of positive patient outcomes, and her commitment to improving the patient experience.
